BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26839161)

  • 1. Can Nup88 expression be associated with atypical endometrial hyperplasia and endometrial cancer? A preliminary study.
    Li Y; Zhang X; Ge J; Liu X; Xu S; Zhu Z; Fang G; Liu J; Zhang H; Sun X
    Pathol Res Pract; 2016 Apr; 212(4):274-8. PubMed ID: 26839161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma.
    Zhang HZ; Li XH; Zhang X; Zhang ZY; Meng YL; Xu SW; Zheng Y; Zhu ZL; Cui DS; Huang LX; Yan BY; Sun XF
    Chemotherapy; 2010; 56(4):291-7. PubMed ID: 20714146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of PTEN expression of endometrial "surface epithelial changes" and underlying atypical endometrial hyperplasia.
    Quddus MR; Ologun BA; Sung CJ; Steinhoff MM; Lawrence WD
    Int J Gynecol Pathol; 2009 Sep; 28(5):471-6. PubMed ID: 19696618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nup88 expression is associated with myometrial invasion in endometrial carcinoma.
    Schneider J; Martínez-Arribas F; Torrejón R
    Int J Gynecol Cancer; 2010 Jul; 20(5):804-8. PubMed ID: 20973273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers.
    Balmer NN; Richer JK; Spoelstra NS; Torkko KC; Lyle PL; Singh M
    Mod Pathol; 2006 Dec; 19(12):1593-605. PubMed ID: 16980945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
    Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
    J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different trends of p53, MDM2 and p14 ARF expression patterns in endometrial adenocarcinomas versus hyperplasia.
    Buchynska LG; Nesina IP; Kashuba EV
    Exp Oncol; 2007 Dec; 29(4):287-94. PubMed ID: 18199985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
    Zhou XH; Teng XD; Song WY; Wu YJ
    Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia.
    Janicek MF; Rosenshein NB
    Gynecol Oncol; 1994 Mar; 52(3):373-8. PubMed ID: 8157194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paired boxed gene 1 expression: A single potential biomarker for differentiating endometrial lesions associated with favorable outcomes in patients with endometrial carcinoma.
    Liu LC; Lai HC; Chou YC; Huang RL; Yu MH; Lin CP; Tsai WC; Chiang KJ; Wang YC; Chao TK
    J Obstet Gynaecol Res; 2016 Sep; 42(9):1159-67. PubMed ID: 27226215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of thyroid transcription factor-1 in normal endometrium is associated with risk of endometrial cancer development.
    Sullivan PS; Maresh EL; Seligson DB; Habeeb O; Wadehra M; Goodglick L; Dorigo O
    Mod Pathol; 2012 Aug; 25(8):1140-8. PubMed ID: 22460811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of cyclin E expression in endometrial hyperplasia and cancer in postmenopausal women].
    Bitner A; Zdziennicki A; Wlaźlak E; Kobos J; Suzin J; Surkont G
    Ginekol Pol; 2014 Sep; 85(9):665-71. PubMed ID: 25322537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasia.
    Allison KH; Upson K; Reed SD; Jordan CD; Newton KM; Doherty J; Swisher EM; Garcia RL
    Int J Gynecol Pathol; 2012 Mar; 31(2):151-159. PubMed ID: 22317873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of PTEN expression as diagnostic marker of endometrial precancer: A systematic review and meta-analysis.
    Raffone A; Travaglino A; Saccone G; Campanino MR; Mollo A; De Placido G; Insabato L; Zullo F
    Acta Obstet Gynecol Scand; 2019 Mar; 98(3):275-286. PubMed ID: 30511743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.
    Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N
    Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maspin expression, subcellular localization and clinicopathological correlation in endometrial hyperplasia and endometrial adenocarcinoma.
    Blandamura S; Alessandrini L; Saccardi C; Giacomelli L; Fabris A; Borghero A; Litta P
    Histol Histopathol; 2014 Jun; 29(6):777-83. PubMed ID: 24346847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ki-67 index as an ancillary tool in the differential diagnosis of proliferative endometrial lesions with secretory change.
    Gurda GT; Baras AS; Kurman RJ
    Int J Gynecol Pathol; 2014 Mar; 33(2):114-9. PubMed ID: 24487464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Morphometry and Matrix Metalloproteinase-9 Expression in Differentiating between Atypical Endometrial Hyperplasia and Low Grade Endometrial Adenocarcinoma.
    Assaf MI; Abd El-Aal W; Mohamed SS; Yassen NN; Mohamed EA
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2291-2297. PubMed ID: 30139240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
    Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
    Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.